Environmental, Social And Governance Report

Overview

The report covers 3D Medicines Inc. and subsidiaries for 2024 and describes Board-level ESG oversight supported by a Board Secretariat and ESG Task Force. Environmental disclosures report 417.35 tCO2e of total GHG emissions, 731,805.5 kWh of electricity consumption, and 2,198.39 m3 of total water consumption. The company reports 191 full-time employees, zero workplace fatalities, and one female director among a seven-member board. It also highlights product accessibility, supplier reviews, quality management, charitable drug assistance, and anti-corruption training.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services